Should We Taper or not: A Short Glance to a Dilemma

Creative Commons License

KULA S., Aykut M., Guler G., Sevik D.

GAZI MEDICAL JOURNAL, vol.29, no.1, pp.85-86, 2018 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 29 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.12996/gmj.2018.24
  • Journal Indexes: Emerging Sources Citation Index, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.85-86


The treatment of the acute inflammatory manifestations of acute rheumatic fever (ARF) refers to the utilization of anti-inflammatory agents. Based upon clinical experience, acetylsalicylic acid (ASA) has been traditionally accepted as the first-line therapy for arthritis. However, various scientific sources indicate different schedules for the administration of ASA treatment and such differences may cause misunderstandings. This student study aims to investigate the approaches for the ASA treatment that have been adopted by the pediatric cardiologists in the treatment of ARF arthritis by means of a pre-designed questionnaire.